Another country has decided to pause or delay COVID-19 “vaccinations” because of the number of blood clots resulting after shots.
Sweden announced they will not begin vaccinating people with Johnson & Johnson’s Covid-19 shot until the European Medicines Agency (EMA) reviews reports of blood clots, the Swedish Health Agency said.
On Tuesday, the US Food and Drug Administration (FDA) recommended that states pause their use of the J&J vaccine after six of its recipients developed a “severe type of blood clot.”
Johnson & Johnson reacted to the development by delaying delivery of its Covid-19 vaccine to the EU.
The health complications were similar to those that earlier sparked the suspension of the AstraZeneca vaccine in several countries, and which has seen age limits imposed on its use after UK and EU health regulators posted updated reviews of it.